Pyrrole derivatives as phosphodiesterase VII inhibitors

   
   

Compounds of the formula I ##STR1## in which R.sup.1 and R.sup.2, independently of one another, each denote H, A, OA, SA or HaI, R.sup.3 denotes H or A, R.sup.4 denotes A or NH.sub.2, R.sup.5 denotes H, NH.sub.2, NHA or NA.sub.2, A denotes alkyl having 1 to 10 carbon atoms, alkenyl, cycloalkyl or alkylenecycloalkyl, Hal denotes F, Cl, Br or I, and their physiologically acceptable salts and/or solvates, as phosphodiesterase VII inhibitors.

Les composés du ## du ## STR1 de la formule I dans lequel R.sup.1 et R.sup.2, indépendamment d'un un autre, chacun dénotent H, A, bureautique, SA ou HaI, R.sup.3 dénote H ou A, R.sup.4 dénote A ou NH.sub.2, R.sup.5 dénote H, NH.sub.2, NHA ou NA.sub.2, A dénote l'alkyl ayant 1 à 10 atomes de carbone, alkényle, cycloalkyl ou l'alkylenecycloalkyl, Hal dénote F, Cl, Br ou I, et leurs sels et/ou solvates physiologiquement acceptables, comme inhibiteurs de la phosphodiestérase VII.

 
Web www.patentalert.com

< Induction of programmed cell death by N5 gene

< Tag encasement

> Aluminum alloy, aluminum alloy foil, container and method of preparing aluminum alloy foil

> Method for manufacturing elements of composite materials by the co-bonding technique

~ 00113